Dynavax Financial Statements From 2010 to 2021

DVAX -  USA Stock  

USD 18.79  2.99  18.92%

Dynavax Technologies financial statements provide useful quarterly and yearly information to potential Dynavax Technologies investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Dynavax Technologies financial statements helps investors assess Dynavax Technologies' valuation, profitability, and current liquidity needs.
We have found one hundred two available fundamental signals for Dynavax Technologies, which can be analyzed and compared to other ratios and to its rivals. Make sure you verify all of Dynavax Technologies prevailing market performance against the performance between 2010 and 2021 to make sure the company can sustain itself down the road.
Dynavax Technologies Average Equity is fairly stable at the moment as compared to the past year. Dynavax Technologies reported Average Equity of 49.52 Million in 2020. Enterprise Value is likely to rise to about 681.3 M in 2021, whereas Net Income Per Employee is likely to drop (330.4 K) in 2021.

Search Financial Statements 

 
Refresh
Check Dynavax Technologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dynavax main balance sheet or income statement drivers, such as Direct Expenses of 18 M, Cost of Revenue of 15.5 M or Gross Profit of 35.2 M, as well as many exotic indicators such as Long Term Debt to Equity of 3.85, PPandE Turnover of 1.59 or Receivables Turnover of 3.02. Dynavax financial statements analysis is a perfect complement when working with Dynavax Technologies Valuation or Volatility modules. It can also supplement various Dynavax Technologies Technical models. Continue to the analysis of Dynavax Technologies Correlation against competitors.

Dynavax Technologies Revenues

50.23 MillionShare

Dynavax Technologies Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets295.9 M353.3 M198.8 M
Increasing
Slightly volatile
Cash and Equivalents35.8 M32.3 M32.8 M
Increasing
Slightly volatile
Investments133.3 M133 M111.3 M
Increasing
Slightly volatile
Investments Current133.3 M133 M111.3 M
Increasing
Slightly volatile
Deferred Revenue47.4 M43.9 M24.7 M
Increasing
Slightly volatile
Property Plant and Equipment Net61.7 M57.1 M23.6 M
Increasing
Slightly volatile
Inventory51.5 M63.7 M14.8 M
Increasing
Slightly volatile
Trade and Non Trade Receivables24.5 M22.7 M6.4 M
Increasing
Slightly volatile
Trade and Non Trade Payables3.8 M3.3 M3.6 M
Increasing
Slightly volatile
Goodwill and Intangible Assets3.3 M2.3 M3.7 M
Increasing
Stable
Total Liabilities317.8 M294.6 M104 M
Increasing
Slightly volatile
Shareholders Equity75.3 M58.7 M102.9 M
Decreasing
Stable
Accumulated Other Comprehensive Income294.6 K273 K(1.3 M)
Increasing
Very volatile
Current Assets247.8 M290 M171.3 M
Increasing
Slightly volatile
Assets Non Current68.3 M63.3 M29.2 M
Increasing
Slightly volatile
Current Liabilities83.5 M77.4 M34.7 M
Increasing
Slightly volatile
Liabilities Non Current234.3 M217.2 M69.3 M
Increasing
Slightly volatile
Total Debt231.5 M214.6 M93.2 M
Increasing
Slightly volatile
Debt Current11.5 M11.5 M12.6 M
Decreasing
Slightly volatile
Debt Non Current176.9 M214.6 M88.4 M
Increasing
Slightly volatile
Shareholders Equity USD75.3 M58.7 M102.9 M
Decreasing
Stable
Cash and Equivalents USD35.8 M32.3 M32.8 M
Increasing
Slightly volatile
Total Debt USD231.5 M214.6 M93.2 M
Increasing
Slightly volatile
Accounts Payable3.2 M3.3 M3.5 M
Increasing
Slightly volatile
Receivables24.5 M22.7 M6.4 M
Increasing
Slightly volatile
Inventories68.7 M63.7 M16.3 M
Increasing
Slightly volatile

Dynavax Technologies Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Revenues50.2 M46.6 M19.4 M
Increasing
Slightly volatile
Cost of Revenue15.5 M13.9 M6.7 M
Increasing
Slightly volatile
Selling General and Administrative Expense63.4 M79.3 M39.6 M
Increasing
Slightly volatile
Research and Development Expense29.4 M28.6 M60.1 M
Decreasing
Stable
Operating Expenses111.9 M101 M102.3 M
Increasing
Slightly volatile
Interest Expense20.6 M19.1 M7.6 M
Increasing
Slightly volatile
Preferred Dividends Income Statement ImpactM2.9 MM
Decreasing
Slightly volatile
Weighted Average Shares108.7 M100.8 M46 M
Increasing
Slightly volatile
Weighted Average Shares Diluted109.5 M101.5 M46.1 M
Increasing
Slightly volatile
Revenues USD50.2 M46.6 M19.4 M
Increasing
Slightly volatile
Gross Profit35.2 M32.6 M13.5 M
Increasing
Very volatile
Direct Expenses18 M13.9 M20.6 M
Decreasing
Slightly volatile

Dynavax Technologies Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Capital ExpenditureM2.8 M(3.7 M)
Decreasing
Stable
Net Cash Flow Investment Acquisitions and Disposals(24.1 M)(22.3 M)(13.3 M)
Increasing
Stable
Net Cash Flow from Financing115.5 M109.5 M101.2 M
Increasing
Stable
Issuance Repayment of Debt Securities 92.1 M85.4 M42.7 M
Increasing
Slightly volatile
Issuance Purchase of Equity Shares104.2 M109.5 M82.4 M
Increasing
Very volatile
Net Cash Flow from Investing(28.6 M)(26.5 M)(19.7 M)
Increasing
Very volatile
Effect of Exchange Rate Changes on Cash 1.6 M1.5 M186 K
Increasing
Slightly volatile
Net Cash Flow or Change in Cash and Cash Equivalents(8 M)(7.8 M)(1.1 M)
Decreasing
Very volatile
Share Based Compensation14.3 M13.5 M12.6 M
Increasing
Slightly volatile
Depreciation Amortization and Accretion5.6 M6.8 M3.6 M
Increasing
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Gross Margin0.760.7010.3832
Decreasing
Slightly volatile
Asset Turnover0.120.1440.1135
Decreasing
Slightly volatile
Sales per Share0.540.4620.6859
Decreasing
Slightly volatile
Price to Sales Ratio9.889.631290
Increasing
Stable
Price to Book Value10.228.35310.0669
Increasing
Slightly volatile
Debt to Equity Ratio4.865.0193.9182
Increasing
Slightly volatile
Current Ratio4.623.7466.1492
Decreasing
Stable
Book Value per Share0.60.5834.0381
Decreasing
Slightly volatile
Tangible Assets Book Value per Share4.433.4846.0215
Decreasing
Slightly volatile
Total Assets Per Share4.773.2065.2779
Decreasing
Slightly volatile
Receivables Turnover3.022.94326.3714
Decreasing
Slightly volatile
Inventory Turnover0.270.26491.7892
Decreasing
Slightly volatile
PPandE Turnover1.591.48351.409
Decreasing
Slightly volatile
Cash and Equivalents Turnover1.391.29030.6028
Increasing
Stable
Accounts Payable Turnover6.937.37475.4068
Decreasing
Slightly volatile
Accrued Expenses Turnover1.882.27421.2379
Decreasing
Stable
Long Term Debt to Equity3.853.06362.9551
Increasing
Slightly volatile
Quick Ratio2.492.42475.6029
Decreasing
Slightly volatile
Net Current Assets as percentage of Total Assets73.2760.181471.9704
Decreasing
Slightly volatile
Revenue to Assets0.130.13180.0996
Decreasing
Stable

Dynavax Technologies Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Capitalization574.6 M490.3 M549.2 M
Increasing
Stable
Enterprise Value681.3 M672.6 M574.9 M
Increasing
Slightly volatile
Invested Capital491.8 M455.9 M201.3 M
Increasing
Slightly volatile
Average Equity50.8 M49.5 M92.1 M
Decreasing
Very volatile
Average Assets273.1 M323.8 M185.3 M
Increasing
Slightly volatile
Invested Capital Average474.2 M439.5 M190.7 M
Increasing
Slightly volatile
Tangible Asset Value292.6 M351 M195.1 M
Increasing
Slightly volatile
Working Capital189.5 M212.6 M138.7 M
Increasing
Slightly volatile
Revenue Per Employee150.1 K189.5 K92.3 K
Increasing
Very volatile

Dynavax Fundamental Market Drivers

Short Percent Of Float22.32%
Forward Price Earnings12.78
Shares Short Prior Month18.99M
Average Daily Volume Last 10 Day7.99M
Average Daily Volume In Three Month4.38M
Date Short Interest13th of August 2021
Fifty Day Average15.46
Two Hundred Day Average10.83

Dynavax Upcoming Events

Upcoming Quarterly Report4th of November 2021
Next Earnings Report24th of February 2022
Next Fiscal Quarter End30th of September 2021
Next Fiscal Year End24th of February 2022
Last Quarter Report30th of June 2021
Last Earning Announcement30th of September 2020

About Dynavax Technologies Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Dynavax Technologies income statement, its balance sheet, and the statement of cash flows. Dynavax Technologies investors use historical funamental indicators, such as Dynavax Technologies's revenue or net income, to determine how well the company is positioned to perform in the future. Although Dynavax Technologies investors may use each financial statement separately, they are all related. The changes in Dynavax Technologies's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Dynavax Technologies's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Dynavax Technologies Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Dynavax Technologies. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2021
Deferred Revenue43.9 M47.4 M
Cost of Revenue13.9 M15.5 M
Revenues46.6 M50.2 M
Revenue to Assets 0.13  0.13 
Revenue Per Employee189.5 K150.1 K
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California. Dynavax Technologies operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 245 people.

Dynavax Technologies Investors Sentiment

The influence of Dynavax Technologies' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Dynavax. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Current Sentiment - DVAX

Dynavax Technologies Investor Sentiment

Most of Macroaxis users are currently bullish on Dynavax Technologies. What is your opinion about investing in Dynavax Technologies? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Pair Trading with Dynavax Technologies

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Dynavax Technologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dynavax Technologies will appreciate offsetting losses from the drop in the long position's value.

Dynavax Technologies Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Dynavax Technologies and Equillium. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Continue to the analysis of Dynavax Technologies Correlation against competitors. Note that the Dynavax Technologies information on this page should be used as a complementary analysis to other Dynavax Technologies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Complementary Tools for Dynavax Stock analysis

When running Dynavax Technologies price analysis, check to measure Dynavax Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dynavax Technologies is operating at the current time. Most of Dynavax Technologies' value examination focuses on studying past and present price action to predict the probability of Dynavax Technologies' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Dynavax Technologies' price. Additionally, you may evaluate how the addition of Dynavax Technologies to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
CEO Directory
Screen CEOs from public companies around the world
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
The market value of Dynavax Technologies is measured differently than its book value, which is the value of Dynavax that is recorded on the company's balance sheet. Investors also form their own opinion of Dynavax Technologies' value that differs from its market value or its book value, called intrinsic value, which is Dynavax Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dynavax Technologies' market value can be influenced by many factors that don't directly affect Dynavax Technologies underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dynavax Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine Dynavax Technologies value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dynavax Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.